5 minute read
Jun. 18, 2022
Pevonedistat: a First-In-Class NEDD8-Activating Enzyme (NAE) Inhibitor
pevonedistat
intravenous NEDD8-activating enzyme inhibitor Ph. III candidate for oncology from HTS and optimization Drug Metab. Dispos., July, 2022 Takeda, Lexington, MA
Loading...
